CDMO
Companies
NASDAQ
Avid Bioservices Inc.
Health Care
$12.49
+$0.25 (+2.04%)
Price Chart
Overview
About CDMO
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Market Cap
$505.3M
Volume
Avg. Volume
P/E Ratio
Dividend Yield
0.00%
Employees
336.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.77
Moderate Correlation
Volatility
High (0.57)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CDMO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$505.3M
Volume
P/E Ratio
Dividend Yield0.00%
Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025